We now explored in more detail, in how far the auxiliary assessment of ERCC1-transcripts influences overall CTC-detection rate and whether this molecular marker may improve the phenotypic range of CTC-detection by the AdnaTest Ovarian Cancer platform. Here, ERCC1 is linked to ovarian cancer.